Long-Term Persistence of Robust Antibody and Cytotoxic T Cell Responses in Recovered Patients Infected with SARS CoronavirusResearch Article Published on 2006-12-202022-10-28 Journal: PLoS ONE [Category] Coronavirus, [키워드] against SARS-CoV Analysis antibody change changes in characterized clinical recovery CTL CTL epitope cytotoxic effective found humoral immune response immunological implication individual individuals Infected Infection Intervention moderate MOST N protein onset of symptoms outcome Patient peptides peripheral lymphocyte persistence recovered recovered patient response responses restored robust SARS Coronavirus SARS-CoV SARS-CoV-specific antibody study period subject Support T cell the disease therapeutic agent Vaccine [DOI] 10.1371/journal.pone.0000024 PMC 바로가기 [Article Type] Research Article